Furthermore, Ephexin4 is involved in cancer cell migration; therefore, it would be interesting to investigate whether a mutation of Ephexin4 that abrogates its intermolecular interaction occurs in any metastatic cancer. The gene discussed is ARHGEF16; the disease is metastatic malignant neoplasm.